Sharp (In Good Faith) tells an engaging tale of intrigue, deceit, and pressure for profit in the
American pharmaceutical industry. She traces the history of the drug Procrit, a once widely
prescribed drug marketed to cancer, HIV, and dialysis patients and prescribed as a fatigue
reliever. Two pharmaceutical companies, Amgen and Ortho (a division of Johnson and
Johnson), owned the licensing rights to Procrit and each had purview over certain areas of
the drug's use. Drawing on extensive interviews with an Ortho salesman, Sharp shows how
the companies manipulated the FDA approval processes, enticed doctors, and pressed for
ever wider uses for the drug. In so doing she paints a vivid picture of a pharmaceutical
industry culture that values sales and revenues above all. VERDICTA page-turner, this
alarming chronicle of profit seeking in American medicine will appeal to all who are invested
in the health care they receive or the drugs they're prescribed. [See Prepub Alert, 3/21/11.]--
A.W. Klink, Duke Univ., Durham, NC
Sharp, Kathleen. Blood Feud: The Man Who Blew the Whistle on One of the Deadliest
Prescription Drugs Ever.
不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器 不要翻译器